cancer recurrence

Beyond Survival: Longitudinal Health-related Quality of Life After Hepatectomy for High-risk Colorectal Liver Metastases

By MedXY 08/22/2026

This prospective study reveals that health-related quality of life (HR-QoL) declines immediately after hepatectomy for high-risk colorectal liver metastases but returns to or surpasses baseline by one year in patients without recurrence, underscoring the impact of cancer recurrence on long-term quality of life.

news Oncology Otorhinolaryngology

Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer

By MedXY 04/11/2026

This study identifies clinicopathologic factors linked to pre- and postoperative levels of circulating tumor HPV DNA (ctHPVDNA) in HPV-mediated oropharyngeal cancer patients treated with upfront surgery, offering insights for disease monitoring and clinical trial design.

General Surgery news Oncology

Defining Cure in Stage II-III Colon Cancer: Insights from a Pooled Analysis of 15 Randomized Trials

By MedXY 10/04/2025

A rigorous pooled analysis of over 35,000 patients identifies a recurrence risk below 0.5% at 6 years post-surgery, providing a practical benchmark for defining cure in stage II-III colon cancer and refining patient management strategies.

Clinical Updates Infectious Diseases news Oncology Specialties

Nature: Influenza and SARS‑CoV‑2 can awaken dormant breast cancer cells and trigger lung metastasis

By MedXY 08/10/2025

A Nature paper shows influenza and SARS‑CoV‑2 lung infections can reactivate dormant disseminated breast cancer cells (DCCs) via IL‑6 and CD4+ T‑cell–mediated mechanisms, with concordant human data linking SARS‑CoV‑2 infection to higher cancer‑related mortality and pulmonary metastasis risk.